HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Andreas Rosenwald Selected Research
Andreas Rosenwald Research Topics
Disease
119
Neoplasms (Cancer)
05/2022 - 04/2002
54
Lymphoma (Lymphomas)
01/2022 - 12/2003
48
Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
10/2022 - 06/2002
32
Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
02/2021 - 11/2005
29
B-Cell Lymphoma (Lymphoma, B Cell)
04/2021 - 12/2002
20
Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
01/2022 - 05/2002
19
Disease Progression
12/2021 - 09/2004
19
Multiple Myeloma
10/2021 - 01/2012
15
Burkitt Lymphoma (Burkitt's Lymphoma)
02/2020 - 06/2006
14
Hodgkin Disease (Hodgkin's Disease)
06/2022 - 11/2004
13
Non-Hodgkin Lymphoma (Lymphosarcoma)
10/2022 - 06/2003
12
Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
01/2021 - 04/2002
11
T-Cell Lymphoma (Lymphoma, T Cell)
01/2022 - 06/2009
8
B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2016 - 06/2003
7
Carcinogenesis
04/2022 - 04/2009
7
Genetic Translocation (Chromosomal Translocation)
12/2016 - 12/2002
6
Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 08/2010
6
Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
11/2021 - 06/2009
6
Graft vs Host Disease (Graft-Versus-Host Disease)
01/2021 - 01/2015
5
Infections
01/2021 - 06/2003
5
Neoplasm Metastasis (Metastasis)
01/2019 - 01/2012
5
Adrenocortical Carcinoma
12/2018 - 11/2015
4
Carcinoma (Carcinomatosis)
01/2022 - 08/2004
4
Inflammation (Inflammations)
01/2021 - 10/2010
4
Leukemia
05/2017 - 06/2004
3
Adenoma (Adenomas)
01/2022 - 03/2012
3
Breast Neoplasms (Breast Cancer)
01/2021 - 03/2008
3
Melanoma (Melanoma, Malignant)
01/2019 - 08/2013
2
Hematologic Neoplasms (Hematological Malignancy)
01/2022 - 11/2013
Drug/Important Bio-Agent (IBA)
41
Proteins (Proteins, Gene)
FDA Link
12/2022 - 04/2002
21
Biological Products
IBA
04/2022 - 05/2002
19
Biomarkers (Surrogate Marker)
IBA
04/2022 - 07/2006
19
Rituximab (Mabthera)
FDA Link
07/2021 - 01/2011
17
DNA (Deoxyribonucleic Acid)
IBA
10/2021 - 06/2002
14
Paraffin
IBA
11/2017 - 10/2008
12
MicroRNAs (MicroRNA)
IBA
12/2022 - 09/2008
12
Messenger RNA (mRNA)
IBA
11/2021 - 02/2003
12
RNA (Ribonucleic Acid)
IBA
10/2021 - 05/2005
12
Vincristine (Oncovin)
FDA Link
Generic
04/2021 - 12/2011
12
Phosphotransferases (Kinase)
IBA
01/2020 - 09/2005
11
Antigens
IBA
01/2022 - 05/2002
11
Doxorubicin (Adriamycin)
FDA Link
Generic
04/2021 - 12/2011
11
Prednisone (Sone)
FDA Link
Generic
01/2021 - 12/2011
11
Cyclin D1
IBA
01/2021 - 02/2003
11
Cyclophosphamide (Cytoxan)
FDA Link
Generic
01/2021 - 12/2011
11
Formaldehyde (Formol)
FDA Link
11/2017 - 10/2008
9
Pharmaceutical Preparations
IBA
04/2022 - 09/2004
9
Antibodies
IBA
01/2022 - 04/2009
7
Cyclins
IBA
01/2021 - 12/2005
7
Protein Isoforms (Isoforms)
IBA
02/2017 - 06/2007
7
Complementary DNA (cDNA)
IBA
01/2013 - 07/2003
7
NF-kappa B (NF-kB)
IBA
05/2008 - 12/2002
6
Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)
IBA
10/2021 - 06/2003
6
ibrutinib
IBA
02/2021 - 09/2014
6
Immunoglobulin M (IgM)
IBA
01/2019 - 04/2004
6
Immunoglobulins (Immunoglobulin)
IBA
01/2019 - 12/2002
6
Anaplastic Lymphoma Kinase
IBA
05/2014 - 04/2002
5
Etoposide (VP 16)
FDA Link
Generic
04/2021 - 11/2011
5
Cytokines
IBA
01/2020 - 02/2003
5
carboxyl radical (COO-)
IBA
09/2018 - 06/2011
4
Keratins (Keratin)
IBA
01/2022 - 01/2012
4
Methotrexate (Mexate)
FDA Link
Generic
01/2022 - 10/2013
4
Dexamethasone (Maxidex)
FDA Link
Generic
01/2021 - 11/2011
4
Cytarabine (Cytosar-U)
FDA Link
Generic
01/2021 - 11/2011
4
Monoclonal Antibodies
IBA
01/2021 - 08/2013
4
Ligands
IBA
01/2021 - 11/2005
4
T-Cell Antigen Receptors (T-Cell Receptor)
IBA
07/2019 - 11/2004
3
Mitogen-Activated Protein Kinases
IBA
05/2022 - 10/2010
3
Chemokine Receptors
IBA
01/2022 - 04/2015
3
Lenalidomide (CC 5013)
FDA Link
01/2021 - 09/2016
3
Autoantigens
IBA
01/2021 - 11/2015
3
RNA-Directed DNA Polymerase (Reverse Transcriptase)
IBA
01/2020 - 07/2007
3
Peptides (Polypeptides)
IBA
01/2020 - 11/2013
3
Proteasome Endopeptidase Complex (Proteasome)
IBA
01/2019 - 03/2009
3
Chemokines
IBA
10/2018 - 03/2009
3
Endoplasmic Reticulum Chaperone BiP
IBA
09/2016 - 01/2013
3
Glucose (Dextrose)
FDA Link
Generic
09/2016 - 08/2013
3
Bortezomib (Velcade)
FDA Link
09/2016 - 03/2009
3
Transcription Factors (Transcription Factor)
IBA
09/2015 - 05/2005
3
Cisplatin (Platino)
FDA Link
Generic
01/2014 - 03/2008
3
Tyrosine (L-Tyrosine)
FDA Link
01/2013 - 12/2010
3
Cyclin D2
IBA
11/2009 - 02/2004
3
Indicators and Reagents (Reagents)
IBA
01/2007 - 12/2005
2
Cre recombinase
IBA
12/2022 - 10/2010
2
Insulin (Novolin)
FDA Link
12/2022 - 01/2022
2
Tetracycline (Achromycin)
FDA Link
Generic
12/2022 - 05/2009
2
Gemcitabine
FDA Link
01/2022 - 11/2017
2
Brentuximab Vedotin
IBA
01/2022 - 01/2014
2
Nivolumab
IBA
01/2022 - 01/2020
2
68Ga-pentixafor
IBA
01/2022 - 11/2017
2
obinutuzumab
IBA
01/2022 - 04/2020
2
Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)
IBA
12/2021 - 01/2021
Therapy/Procedure
52
Therapeutics
10/2022 - 02/2003
16
Drug Therapy (Chemotherapy)
04/2021 - 06/2002
8
Stem Cell Transplantation
04/2021 - 11/2011
6
Immunotherapy
10/2021 - 01/2013
4
Aftercare (After-Treatment)
10/2021 - 05/2017
3
Cell Transplantation
01/2021 - 01/2013
3
Radiotherapy
01/2021 - 11/2019
3
Salvage Therapy
01/2020 - 11/2011